Growing cases of epilepsy in the country is expected to drive the growth of India oxcarbazepine market during the forecast period.
According to TechSci Research report, “India Oxcarbazepine Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet v/s Oral Suspension), By Distribution Channel (Online v/s Offline), By Application (Epilepsy, Neuropathic Pain, Seizures and Others), By End User (Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2027”, the India oxcarbazepine market is expected to grow at a steady rate during the forecast period. The medication alone is very effective in treating partial seizures in children of 4 years and older which is expected to fuel the market growth through FY2027. Also, this drug is used in combination with other medications to treat partial seizures in children of 2 years old and above by inhibiting abnormal electrical activity in the brain. However, side-effects associated with drug consumption such as nausea, vomiting, double vision, dizziness, drowsiness and trouble with walking can restrict the market growth over the next few years. Moreover, in some severe cases, side effects such as liver problems, anaphylaxis, pancreatitis and an abnormal heartbeat. can occur. This can further reduce the usage and application of the drug thereby hindering the market growth during the forecast period.
Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on “India Oxcarbazepine Market” https://www.techsciresearch.com/report/india-oxcarbazepine-market/7312.html
The India oxcarbazepine market is segmented based on source, form, distribution channel, application, end user, company, and region. Based on end user, the market can be fragmented into adult v/s pediatric. The adult segment dominated the market until FY2020 and is further forecasted to maintain its dominance during the forecast period as well. This dominance can be accredited to the wide use of oxcarbazepine in adults to treat epilepsy, as this condition is most commonly diagnosed in people over 65 years of age. The pediatric segment is expected to grow at a high CAGR in the market during forthcoming years on account of rising epileptic condition in people under 20. The most common conditions for epilepsy in children includes difficulties at their birth, childhood infections or accidents. Based on application, the market can be categorized into epilepsy, neuropathic pain, seizures and others. The epilepsy segment dominated the market until FY2020 due to rising prevalence of epilepsy in the country. Neuropathic pain application segment is forecasted to witness high growth in the next 5 years which can be accredited to effectiveness of this drug in treating this condition.
Sun Pharmaceuticals Industries Ltd., Intas Pharmaceutical Ltd., Sunrise Remedies Pvt. Ltd., Cipla Limited, Zydus Cadila Healthcare Ltd., Nicholas Piramal India Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Consern Pharma Pvt. Ltd., Glenmark Lifesciences Ltd. and others are some of the leading players operating in India oxcarbazepine market. Companies operating in the market are using strategies such as product launches, mergers and acquisitions and research collaborations to boost their share and increase their geographic reach.
Download Free Sample Report @
https://www.techsciresearch.com/sample-report.aspx?cid=7312
Customers can also request for 10% free customization on this report.
“India oxcarbazepine market is expected to witness growth during the forecast period as it is used to treat patients with bipolar disorders. In addition to this, oxcarbazepine has a reduced propensity for involvement in drug-drug interactions when compared to other anti-epileptic drugs which can be attributed to its primarily reductive metabolism, causing less side effects. This is further expected to create lucrative opportunities for the market growth of India oxcarbazepine market over the next five years.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based India management consulting firm.
“India Oxcarbazepine Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet v/s Oral Suspension), By Distribution Channel (Online v/s Offline), By Application (Epilepsy, Neuropathic Pain, Seizures and Others), By End User (Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2027”, has evaluated the future growth potential of India oxcarbazepine market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in India oxcarbazepine market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Web: https://www.techsciresearch.com/
